摘要
目的:探讨吸烟急性冠状动脉综合征(ACS)患者血清脂蛋白相关磷脂酶A2(LP-PLA2)的变化,进一步阐明吸烟对该物质的影响及与冠心病的关系。方法:入选170例于2015-01至2015-12因胸痛在我院行冠状动脉造影患者,依据临床表现、冠状动脉造影结果及吸烟史分为:(1)对照组(70例),包括吸烟对照亚组(31例)及非吸烟对照亚组(39例);(2)ACS组(100例),包括吸烟ACS亚组(50例)及非吸烟ACS亚组(50例)。检测血清LP-PLA2、C反应蛋白(CRP)水平。结果:吸烟对照亚组血清LP-PLA2水平高于非吸烟对照亚组(P=0.018),吸烟ACS亚组血清LP-PLA2水平高于非吸烟ACS亚组(P=0.027),ACS组血清LP-PLA2水平显著高于对照组(P=0.000)。血清LP-PLA2水平与CRP呈正相关(r=0.724,P<0.01)。结论:ACS患者血清LP-PLA2、CRP水平较无冠心病者明显升高,提示二者可能直接参与了冠心病的发生、发展,且吸烟者LP-PLA2水平更高,这可能是吸烟者更易罹患冠心病并加重病情进展的原因之一。
Objective: To explore serum levels of lipoprotein associated phospholipase A2( LP-PLA2) in patients with acute coronary syndrome(ACS) who is smoking, to further clarify the impact of smoking on LP-PLA2 and the relationship with coronary artery disease(CAD).Methods: A total of 170 patients who received coronary angiography(CAG) because of chest pain in our hospital from 2015-01 to 2015-12 were enrolled. According to CAG results and smoking history, the patients were divided into 2 groups: Control group, n=70 healthy subjects including 2 subgroups as Smoking control subgroup, n=31 and Non-smoking control subgroup, n=39; ACS group, n=100 patients including 2 subgroups as Smoking ACS and Non-smoking ACS subgroups, n=50 in each subgroup. Blood levels of LP-PLA2 and C-reactive protein(CRP) were detected and compared among different groups. Results: Serum levels of LP-PLA2 in Smoking control subgroup was higher than Non-smoking control subgroup, P=0.018; LP-PLA2 level in Smoking ACS subgroup was higher than Non-smoking ACS subgroup, P=0.027; LP-PLA2 level in ACS group was higher than Control group, P=0.000. Serum levels of LP-PLA2 was positively related to CRP(r=0.724, P〈0.01).Conclusion: Blood levels of LP-PLA2 and CRP were increased in ACS patients suggesting both of them might be involved in CAD occurrence; LP-PLA2 level was even higher in smokers implying this is could be one of the reasons for smokers were more likely to suffer from CAD and aggravate CAD progress.
出处
《中国循环杂志》
CSCD
北大核心
2016年第7期636-639,共4页
Chinese Circulation Journal